BroadcastMed proudly announces the acquisition of Texere Publishing Ltd., an esteemed leader providing B2B media services to audiences in the UK, Europe, and the US. This strategic move underscores BroadcastMed's unwavering commitment being the leading healthcare marketplace to provide trusted clinical content, powerful engagement and industry insights to healthcare professionals, medical institutions and manufacturers, service providers, and pharmaceutical companies.

With this acquisition, BroadcastMed expands its total reach to over 3 million healthcare professionals across 16 adult specialties and 10 pediatric specialties worldwide. The official announcement was made today, supported by the strategic partnership with growth capital firm 424 Capital.

"Texere is thrilled to join forces with the innovators at BroadcastMed to better serve scientific and healthcare providers globally," said Andrew Davies, Texere Publishing's Co-Founder and CEO, "Joining forces with BroadcastMed aligns with our vision for growth and expands our reach by leveraging our combined expertise and resources to deliver even greater value to our audience and partners."

BroadcastMed's dedication to providing physicians and allied healthcare professionals with unparalleled content and leading-edge digital solutions align seamlessly with Texere's commitment to reporting on the latest research, societal impact, professional development, career, and business issues. This shared vision between BroadcastMed and Texere aims to improve patient outcomes through industry-leading clinical content.

"This acquisition furthers BroadcastMed's remarkable growth trajectory, as the company continues to expand the global conversation on healthcare," stated Peter Gailey, President of BroadcastMed. "Our acquisition of Texere widens BroadcastMed's global reach and enhances the company's impact, not only within the healthcare sector but also among audiences in the science and technology fields."